Log in

Motif Bio News Headlines (LON:MTFB)

GBX 0.65
-0.02 (-2.99 %)
(As of 10/14/2019 09:13 AM ET)
Today's Range
0.60
Now: GBX 0.65
0.67
50-Day Range
0.60
MA: GBX 2.05
2.75
52-Week Range
0.45
Now: GBX 0.65
44.90
Volume1.22 million shs
Average Volume400,302 shs
Market Capitalization£2.23 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Motif Bio (LON MTFB) News Headlines

Source:
DateHeadline
Motif Bio Meeting With US FDA Confirms Need For Another iclaprim TrialMotif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial
www.lse.co.uk - October 10 at 7:31 AM
Motif Bio (LON:MTFB) Rating Reiterated by Peel HuntMotif Bio (LON:MTFB) Rating Reiterated by Peel Hunt
www.americanbankingnews.com - October 1 at 7:14 AM
Motif Bio submits Type B meeting request to FDAMotif Bio submits Type B meeting request to FDA
seekingalpha.com - July 15 at 10:14 AM
HOME, CLDR and MIK among premarket losersHOME, CLDR and MIK among premarket losers
seekingalpha.com - June 6 at 10:23 AM
Motif Bio not quite there with iclaprim NDA; shares down 35% premarketMotif Bio not quite there with iclaprim NDA; shares down 35% premarket
seekingalpha.com - June 6 at 10:23 AM
Motif Bio to evaluate iclaprim in ophthalmology; shares up 8% premarketMotif Bio to evaluate iclaprim in ophthalmology; shares up 8% premarket
seekingalpha.com - May 22 at 10:04 AM
Motif Bio meeting with U.S. FDA held as plannedMotif Bio meeting with U.S. FDA held as planned
finance.yahoo.com - May 3 at 5:41 PM
Motif Bio +10% on new Iclaprim dataMotif Bio +10% on new Iclaprim data
seekingalpha.com - April 16 at 11:20 AM
Motif Bio Reports Fiscal Year 2018 ResultsMotif Bio Reports Fiscal Year 2018 Results
finance.yahoo.com - April 15 at 10:20 AM
Motif Bio granted meeting with regarding iclaprim; shares up 57% premarketMotif Bio granted meeting with regarding iclaprim; shares up 57% premarket
seekingalpha.com - March 21 at 8:51 AM
Motif Bio plc Estimate MomentumMotif Bio plc Estimate Momentum
www.nasdaq.com - March 20 at 10:52 PM
AUPH, LXRX and TEUM among premarket gainersAUPH, LXRX and TEUM among premarket gainers
seekingalpha.com - March 20 at 9:45 AM
MTFB: FDA Issues CRL for Iclaprim…MTFB: FDA Issues CRL for Iclaprim…
finance.yahoo.com - February 20 at 10:36 AM
Motif Bio down 17% premarket on expected capital raiseMotif Bio down 17% premarket on expected capital raise
seekingalpha.com - February 19 at 10:32 AM
SIX, MTFB and NTAP among premarket losersSIX, MTFB and NTAP among premarket losers
seekingalpha.com - February 14 at 10:13 AM
Motif Bio PLC ADRMotif Bio PLC ADR
www.barrons.com - January 11 at 5:03 PM
Your Daily Pharma Scoop: Motif Bio NDA Under Review, MiMedx Nixed, Biogen HaltsYour Daily Pharma Scoop: Motif Bio NDA Under Review, MiMedx Nixed, Biogen Halts
seekingalpha.com - August 16 at 9:57 AM
FDA accepts Motif Bios NDA with priority review for IclaprimFDA accepts Motif Bio's NDA with priority review for Iclaprim
seekingalpha.com - August 14 at 10:08 AM
One ‘secret’ growth stock I’d buy alongside this FTSE 100 growth monsterOne ‘secret’ growth stock I’d buy alongside this FTSE 100 growth monster
www.fool.co.uk - April 10 at 4:05 PM
Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS)Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS)
www.morningstar.co.uk - March 8 at 10:25 AM
Motif Bio to Present Iclaprim Data at ECCMID 2018 - GlobeNewswire (press release)Motif Bio to Present Iclaprim Data at ECCMID 2018 - GlobeNewswire (press release)
globenewswire.com - February 23 at 4:29 PM
Appointment of Jonathan E. Gold as Interim Chief Financial Officer - GlobeNewswire (press release)Appointment of Jonathan E. Gold as Interim Chief Financial Officer - GlobeNewswire (press release)
globenewswire.com - February 4 at 8:48 AM
Motif Bio Announces Filing of US Shelf Registration - GlobeNewswire (press release)Motif Bio Announces Filing of US Shelf Registration - GlobeNewswire (press release)
globenewswire.com - January 19 at 5:23 PM
Motif Bio REVIVE-1 Phase 3 Study Results with Iclaprim Published ... - GlobeNewswire (press release)Motif Bio REVIVE-1 Phase 3 Study Results with Iclaprim Published ... - GlobeNewswire (press release)
globenewswire.com - December 21 at 4:57 PM
Poor Industry Group Rank Drops Motif Bio (MTFB) to Hold - Investorplace.comPoor Industry Group Rank Drops Motif Bio (MTFB) to Hold - Investorplace.com
investorplace.com - December 2 at 4:47 PM
Poor Industry Group Rank Drops Motif Bio (MTFB) to HoldPoor Industry Group Rank Drops Motif Bio (MTFB) to Hold
investorplace.com - December 1 at 10:56 AM
Motif Bio (MTFB) Sees Rating Drop….. Wilting Earnings Growth - Investorplace.comMotif Bio (MTFB) Sees Rating Drop….. Wilting Earnings Growth - Investorplace.com
investorplace.com - November 25 at 9:32 AM
Motif Bio secures up to US$20 million debt financing - GlobeNewswire (press release)Motif Bio secures up to US$20 million debt financing - GlobeNewswire (press release)
globenewswire.com - November 15 at 6:33 AM
Motif Bio Presents New Pre-Clinical Data for Iclaprim at IDWeek 2017™ - GlobeNewswire (press release)Motif Bio Presents New Pre-Clinical Data for Iclaprim at IDWeek 2017™ - GlobeNewswire (press release)
globenewswire.com - October 6 at 9:32 AM
Should I pile into Motif Bio plc, up 35% today?Should I pile into Motif Bio plc, up 35% today?
www.fool.co.uk - October 5 at 9:33 AM
Why You Need To Look At This Factor Before Buying Motif Bio plc (MTFB)Why You Need To Look At This Factor Before Buying Motif Bio plc (MTFB)
finance.yahoo.com - October 5 at 9:33 AM
Motif Bio to Host Investor and Analyst Event on September 20, 2017 in New York - GlobeNewswire (press release)Motif Bio to Host Investor and Analyst Event on September 20, 2017 in New York - GlobeNewswire (press release)
globenewswire.com - September 9 at 6:25 AM
Motif Bio to present at upcoming investor and scientific conferences - GlobeNewswire (press release)Motif Bio to present at upcoming investor and scientific conferences - GlobeNewswire (press release)
globenewswire.com - September 1 at 6:06 AM
Motif Bio Announces Result of General Meeting and Total Voting RightsMotif Bio Announces Result of General Meeting and Total Voting Rights
www.nasdaq.com - June 23 at 7:10 PM
Motif Bio Announces Result of General Meeting and Total Voting Rights - GlobeNewswire (press release)Motif Bio Announces Result of General Meeting and Total Voting Rights - GlobeNewswire (press release)
globenewswire.com - June 23 at 8:14 AM
Motif Bio Appoints Scientific Opinion Leaders to Advisory Board - GlobeNewswire (press release)Motif Bio Appoints Scientific Opinion Leaders to Advisory Board - GlobeNewswire (press release)
globenewswire.com - May 10 at 6:44 PM
Motif Bio Appoints Scientific Opinion Leaders to Advisory BoardMotif Bio Appoints Scientific Opinion Leaders to Advisory Board
www.nasdaq.com - May 10 at 12:15 PM
European ADRs Rally, Buoyed by Banking StocksEuropean ADRs Rally, Buoyed by Banking Stocks
www.nasdaq.com - April 24 at 12:14 PM
Clinical trial finishes patient treatment phase - London South East (registration) (blog)Clinical trial finishes patient treatment phase - London South East (registration) (blog)
www.lse.co.uk - January 31 at 7:37 PM
Motif Bio Phase 3 Clinical Trial Finishes Patient Treatment Phase - GlobeNewswire (press release)Motif Bio Phase 3 Clinical Trial Finishes Patient Treatment Phase - GlobeNewswire (press release)
globenewswire.com - January 30 at 7:24 PM
Motif Bio plc Announces Closing of its $25 Million U.S. Initial Public Offering and European PlacementMotif Bio plc Announces Closing of its $25 Million U.S. Initial Public Offering and European Placement
www.nasdaq.com - November 23 at 6:22 PM
Marijuana REIT to Test IPO Market This WeekMarijuana REIT to Test IPO Market This Week
247wallst.com - November 20 at 6:02 PM
Confirms successful European placing - London South East (registration) (blog)Confirms successful European placing - London South East (registration) (blog)
www.lse.co.uk - November 19 at 6:23 PM
Motif Bio plc (MTFB) IPO Opens Lower - StreetInsider.comMotif Bio plc (MTFB) IPO Opens Lower - StreetInsider.com
www.streetinsider.com - November 19 at 6:23 PM
Motif Bio plc (MTFB) IPO Opens LowerMotif Bio plc (MTFB) IPO Opens Lower
www.streetinsider.com - November 19 at 8:57 AM
No IPOs Last Week, All Postponed Until This Week - 24/7 Wall St.No IPOs Last Week, All Postponed Until This Week - 24/7 Wall St.
247wallst.com - November 13 at 10:21 AM
IPO Calendar Thins Out for Election WeekIPO Calendar Thins Out for Election Week
247wallst.com - November 7 at 10:06 AM
High-level changes at Motif BioHigh-level changes at Motif Bio
uk.finance.yahoo.com - November 6 at 6:47 PM
IPO Calendar Thins Out for Election Week - 24/7 Wall St.IPO Calendar Thins Out for Election Week - 24/7 Wall St.
247wallst.com - November 6 at 10:56 AM
Motif Bio Is Well Run But Too RiskyMotif Bio Is Well Run But Too Risky
seekingalpha.com - September 21 at 10:23 AM
This page was last updated on 10/14/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel